Credit Suisse’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-66
Closed -$482 3906
2022
Q4
$482 Hold
66
﹤0.01% 3589
2022
Q3
$0 Hold
66
﹤0.01% 4465
2022
Q2
$0 Buy
+66
New +$515 ﹤0.01% 4534

Other funds holding AMYT

Credit Suisse's AMYT Position: Q1 2023 in Review

Credit Suisse sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 66 shares — an estimated $482 sold.

Credit Suisse first reported a position in AMYT in Q2 2022 and held it in 3 quarters. The position peaked at $482 in Q4 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Credit Suisse reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 66 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $482.
  • Credit Suisse first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2022 and held it in 3 quarters.
  • Credit Suisse's Amryt Pharma plc American Depositary Shares position peaked at $482 in Q4 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.